 James Finigan
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Lung Injury | 5 | 2012 | 288 | 1.370 |
Why?
| | Receptor, ErbB-2 | 5 | 2019 | 342 | 1.310 |
Why?
| | Neuregulin-1 | 5 | 2019 | 46 | 1.110 |
Why?
| | Protein C | 4 | 2012 | 59 | 0.980 |
Why?
| | Respiratory Mucosa | 5 | 2018 | 322 | 0.950 |
Why?
| | Blood Coagulation Factors | 2 | 2012 | 54 | 0.610 |
Why?
| | Receptors, Cell Surface | 3 | 2012 | 386 | 0.600 |
Why?
| | Lung | 8 | 2019 | 4065 | 0.580 |
Why?
| | Cell Membrane Permeability | 1 | 2016 | 80 | 0.500 |
Why?
| | Signal Transduction | 7 | 2019 | 5065 | 0.490 |
Why?
| | ErbB Receptors | 3 | 2016 | 613 | 0.490 |
Why?
| | Lung Neoplasms | 5 | 2020 | 2491 | 0.470 |
Why?
| | Adherens Junctions | 1 | 2014 | 25 | 0.450 |
Why?
| | Epithelial Cells | 2 | 2018 | 1093 | 0.420 |
Why?
| | Cell Adhesion | 1 | 2014 | 467 | 0.400 |
Why?
| | beta Catenin | 1 | 2014 | 251 | 0.390 |
Why?
| | Capillary Permeability | 3 | 2010 | 144 | 0.380 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2012 | 654 | 0.380 |
Why?
| | Respiration, Artificial | 3 | 2012 | 642 | 0.330 |
Why?
| | Permeability | 4 | 2015 | 162 | 0.320 |
Why?
| | Extravascular Lung Water | 1 | 2009 | 7 | 0.320 |
Why?
| | Early Detection of Cancer | 1 | 2013 | 419 | 0.300 |
Why?
| | Smoking | 1 | 2016 | 1633 | 0.290 |
Why?
| | Electric Impedance | 3 | 2016 | 107 | 0.290 |
Why?
| | Transcriptional Activation | 2 | 2011 | 378 | 0.270 |
Why?
| | Glycoproteins | 1 | 2009 | 344 | 0.270 |
Why?
| | Blood Coagulation | 1 | 2008 | 253 | 0.260 |
Why?
| | Epithelium | 3 | 2019 | 311 | 0.260 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2005 | 15 | 0.230 |
Why?
| | Adenocarcinoma | 1 | 2012 | 936 | 0.230 |
Why?
| | Endothelium, Vascular | 2 | 2008 | 925 | 0.220 |
Why?
| | Endothelium | 1 | 2005 | 122 | 0.220 |
Why?
| | Cell Line | 3 | 2016 | 2836 | 0.220 |
Why?
| | Interleukin-6 | 3 | 2019 | 778 | 0.220 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2677 | 0.200 |
Why?
| | ADAM17 Protein | 2 | 2012 | 35 | 0.190 |
Why?
| | ADAM Proteins | 2 | 2012 | 61 | 0.180 |
Why?
| | Hydroxychloroquine | 1 | 2020 | 58 | 0.170 |
Why?
| | Phosphorylation | 4 | 2019 | 1756 | 0.170 |
Why?
| | Pulmonary Medicine | 1 | 2020 | 85 | 0.160 |
Why?
| | RNA, Small Interfering | 3 | 2014 | 621 | 0.160 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2020 | 95 | 0.150 |
Why?
| | Chemokine CCL11 | 1 | 2018 | 26 | 0.150 |
Why?
| | Protein Kinase Inhibitors | 2 | 2014 | 916 | 0.140 |
Why?
| | Tight Junctions | 2 | 2015 | 77 | 0.140 |
Why?
| | Interleukin-13 | 1 | 2018 | 149 | 0.130 |
Why?
| | Alveolar Epithelial Cells | 1 | 2018 | 114 | 0.130 |
Why?
| | Animals | 10 | 2016 | 36768 | 0.130 |
Why?
| | Cell Adhesion Molecules | 1 | 2018 | 181 | 0.130 |
Why?
| | Receptor, ErbB-3 | 1 | 2016 | 44 | 0.130 |
Why?
| | Quinazolines | 2 | 2014 | 249 | 0.130 |
Why?
| | Cluster Analysis | 1 | 2017 | 495 | 0.120 |
Why?
| | Forced Expiratory Volume | 1 | 2017 | 532 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 368 | 0.120 |
Why?
| | Critical Care | 1 | 2020 | 583 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 359 | 0.120 |
Why?
| | Epidermal Growth Factor | 2 | 2012 | 174 | 0.110 |
Why?
| | Humans | 20 | 2020 | 136783 | 0.110 |
Why?
| | Sleep | 1 | 2020 | 751 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 1078 | 0.110 |
Why?
| | Pulmonary Alveoli | 2 | 2015 | 405 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2014 | 813 | 0.100 |
Why?
| | RNA Interference | 1 | 2014 | 464 | 0.100 |
Why?
| | Radiography, Thoracic | 1 | 2013 | 168 | 0.100 |
Why?
| | Mice, Inbred C57BL | 2 | 2016 | 5744 | 0.100 |
Why?
| | History, 20th Century | 1 | 2013 | 323 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1619 | 0.090 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 152 | 0.090 |
Why?
| | Blood-Air Barrier | 1 | 2011 | 11 | 0.090 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2010 | 66 | 0.080 |
Why?
| | Myosin Light Chains | 2 | 2010 | 26 | 0.080 |
Why?
| | Stress, Mechanical | 2 | 2009 | 480 | 0.080 |
Why?
| | Endothelial Protein C Receptor | 1 | 2009 | 5 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2009 | 765 | 0.080 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 1042 | 0.080 |
Why?
| | Pulmonary Edema | 1 | 2009 | 106 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2011 | 372 | 0.080 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 298 | 0.070 |
Why?
| | Capillaries | 1 | 2009 | 108 | 0.070 |
Why?
| | Thrombin | 2 | 2010 | 152 | 0.070 |
Why?
| | rho-Associated Kinases | 1 | 2009 | 83 | 0.070 |
Why?
| | Thromboplastin | 1 | 2008 | 74 | 0.070 |
Why?
| | Gene Expression | 2 | 2010 | 1499 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2018 | 4194 | 0.070 |
Why?
| | Transfection | 2 | 2010 | 945 | 0.070 |
Why?
| | Pulmonary Circulation | 1 | 2009 | 430 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2012 | 1455 | 0.060 |
Why?
| | Protein Binding | 2 | 2019 | 2223 | 0.060 |
Why?
| | Middle Aged | 4 | 2020 | 33200 | 0.060 |
Why?
| | Mice | 4 | 2011 | 17731 | 0.060 |
Why?
| | rac GTP-Binding Proteins | 1 | 2005 | 32 | 0.060 |
Why?
| | Genes, Dominant | 1 | 2005 | 95 | 0.060 |
Why?
| | Threonine | 1 | 2005 | 46 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1683 | 0.060 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2005 | 56 | 0.060 |
Why?
| | Endothelial Cells | 1 | 2010 | 778 | 0.060 |
Why?
| | Immunoprecipitation | 1 | 2005 | 155 | 0.060 |
Why?
| | Polymorphism, Genetic | 2 | 2005 | 657 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2012 | 3537 | 0.060 |
Why?
| | Serine | 1 | 2005 | 141 | 0.060 |
Why?
| | Male | 5 | 2020 | 67361 | 0.050 |
Why?
| | Female | 5 | 2020 | 72840 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2005 | 186 | 0.050 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 397 | 0.050 |
Why?
| | Actins | 1 | 2005 | 415 | 0.050 |
Why?
| | Sepsis | 2 | 2005 | 611 | 0.050 |
Why?
| | Inflammation | 1 | 2012 | 2834 | 0.040 |
Why?
| | Biomarkers | 1 | 2012 | 4158 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2045 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4279 | 0.040 |
Why?
| | Etoposide | 1 | 2020 | 157 | 0.040 |
Why?
| | Treatment Failure | 1 | 2020 | 353 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2019 | 43 | 0.040 |
Why?
| | Advisory Committees | 1 | 2020 | 219 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2019 | 3399 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2005 | 2417 | 0.040 |
Why?
| | Aged | 2 | 2020 | 23729 | 0.040 |
Why?
| | Sirolimus | 1 | 2020 | 275 | 0.040 |
Why?
| | Cisplatin | 1 | 2020 | 318 | 0.040 |
Why?
| | Critical Illness | 1 | 2004 | 807 | 0.040 |
Why?
| | Adult | 3 | 2020 | 37616 | 0.040 |
Why?
| | Betacoronavirus | 1 | 2020 | 267 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2018 | 171 | 0.030 |
Why?
| | Models, Biological | 1 | 2005 | 1769 | 0.030 |
Why?
| | Consensus | 1 | 2020 | 679 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 864 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 412 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 820 | 0.030 |
Why?
| | Europe | 1 | 2017 | 414 | 0.030 |
Why?
| | United States | 3 | 2020 | 14660 | 0.030 |
Why?
| | Computational Biology | 2 | 2014 | 645 | 0.030 |
Why?
| | Up-Regulation | 1 | 2018 | 843 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6792 | 0.030 |
Why?
| | Biological Transport | 1 | 2015 | 411 | 0.030 |
Why?
| | Aniline Compounds | 1 | 2014 | 102 | 0.030 |
Why?
| | Nitriles | 1 | 2014 | 172 | 0.030 |
Why?
| | Quinolines | 1 | 2014 | 177 | 0.030 |
Why?
| | Protein Kinases | 1 | 2014 | 319 | 0.020 |
Why?
| | Tomography, Spiral Computed | 1 | 2011 | 32 | 0.020 |
Why?
| | Mutation | 2 | 2014 | 3953 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2014 | 451 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2011 | 189 | 0.020 |
Why?
| | Occludin | 1 | 2010 | 12 | 0.020 |
Why?
| | Bronchoscopy | 1 | 2011 | 222 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3272 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2014 | 800 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2010 | 320 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3199 | 0.020 |
Why?
| | Body Mass Index | 1 | 2017 | 2364 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2603 | 0.020 |
Why?
| | Global Health | 1 | 2011 | 386 | 0.020 |
Why?
| | Occupational Exposure | 1 | 2011 | 337 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2011 | 1373 | 0.020 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1768 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1354 | 0.020 |
Why?
| | Comorbidity | 1 | 2011 | 1611 | 0.020 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2005 | 7 | 0.010 |
Why?
| | MEDLINE | 1 | 2004 | 20 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2010 | 1162 | 0.010 |
Why?
| | Dogs | 1 | 2005 | 409 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2010 | 2999 | 0.010 |
Why?
| | Genetics, Population | 1 | 2004 | 210 | 0.010 |
Why?
| | Databases, Genetic | 1 | 2004 | 236 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2010 | 2831 | 0.010 |
Why?
| | Genotype | 1 | 2005 | 1919 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 21463 | 0.010 |
Why?
| | Cytokines | 1 | 2005 | 2088 | 0.010 |
Why?
| | Rats | 1 | 2005 | 5628 | 0.010 |
Why?
|
|
Finigan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|